US Patent Issued to Harbour BioMed (Shanghai) on March 4 for "Antibodies binding CTLA-4 and uses thereof" (Dutch, Chinese, American Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,905, issued on March 4, was assigned to Harbour BioMed (Shanghai) Co. Ltd. (Shanghai).

"Antibodies binding CTLA-4 and uses thereof" was invented by Xin Gan (Shanghai), Yun He (Shanghai), Yuqiang Shen (Shanghai), Jiuqiao Zhao (Newton, Mass.), Yiping Rong (Shanghai), Frank Grosveld (Rotterdam, Netherlands), Dubravka Drabek (Rotterdam, Netherlands), Marinus (Rien) Van Haperen (Prinsenbeek, Netherlands) and Rick Janssens (Rotterdam, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are isolated monoclonal antibodies, comprising a CD152-binding domain, wherein the antibodies bind specifically to human CD152. Methods of making and using...